Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Nov;30(11):2313–2322. doi: 10.3201/eid3011.240610

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.

PMC Copyright notice

Forest plot of risk for facial palsy after COVID-19 vaccination in South Korea, 2021–2022. Plot assess facial palsy risk within 28 days of COVID-19 vaccination. Overall risk is shown, as is risk stratified by dose and vaccine type. Squares indicate IRRs; bars indicate 95% CIs. Vaccine types were BNT162b2 (Pfizer-BioNTech, https://www.pfizer.com), mRNA-1273 (Moderna, https://www.modernatx.com), ChAdOx1 nCoV-19 (AstraZeneca, https://www.astrazeneca.com), Ad.26.COV2.S (Janssen, https://www.janssen.com), and NVX-CoV2373 (Novavax, https://www.novavax.com). 1st/2nd dose indicates a first dose of BNT162b2, mRNA-1273, ChAdOx1 nCoV-19, or Ad26.COV2.S and a second dose of BNT162b2, mRNA-1273, or ChAdOx1 nCoV-19. IR, incidence rate; IRR, incidence rate ratio; NA, not applicable.